NPP-4
Skin Toning / Skin Pigmentation
DevelopmentPlanned launch in 2026
Key Facts
Indication
Skin Toning / Skin Pigmentation
Phase
Development
Status
Planned launch in 2026
Company
About Coegin Pharma
Coegin Pharma is a Swedish biotech firm that has transitioned from traditional drug development to focus exclusively on premium cosmetic peptides for hair and skin. Its core strategy leverages the global longevity megatrend, commercializing its patented Follicopeptide® for hair density and developing NPP-4 for skin toning. The company's innovations are built on collaborations with leading universities and are driven by a management team with deep expertise in biotechnology and commercialization.
View full company profile